glp-1 for obesity GLP-1s Weight Loss: What You Need to Know The Unstoppable Rise of GLP-1

Lexarias Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule lexariabioscience.com/2026/06/23/lex $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes Lexaria Bioscience Corp is a research-driven company that has developed a patented DehydraTECH tech that promotes faster delivery of drugs into the blood $LEXX Joined July 2020 Lexarias Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule lexariabioscience.com/2026/06/23/lex $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes Lexaria Updates Progress on Human Study #7 lexariabioscience.com/2026/05/05/lex $LEXX #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs - Amycretin and retatrutide to be tested for compatibility with DehydraTECH lexariabioscience.com/2026/04/23/lex #Biotech #DrugDelivery #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes Lexaria to Begin New Human Clinical Study in GLP-1 - Contracts signed for Human Pilot Study #7 (GLP-1-H26-7) lexariabioscience.com/2026/04/01/lex #Biotech #nasdaq #DrugDelivery #markets #stocks #stockmarket #investing #stockmarketnews #trading #weightloss #glp1 #diabetes Lexarias Robust Patent Portfolio Continues to Grow - Lexaria receives 5 new patents including 2 for diabetes treatment utilizing GLP-1 drugs lexariabioscience.com/2026/03/26/lex

PlexusDx does not sell, prescribe, or recommend ipamorelin, tesamorelin, or other compounds in this category beyond the longevity products in its protocol line

Patients are usually monitored throughout the procedure to ensure comfort and address any potential reactions that may arise

Meaningful weight loss improved insulin resistance treating the root metabolic load that drives hyperglycemia